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Abstract
Infertility is a common problem in modern societies with significant socio-psychological implications for women. Therapeutic 
interventions are often needed which, depending on the cause, can either be medical treatment, surgical procedures or assisted 
reproductive technology (ART). However, the treatment of infertility is not always successful due to our limited understanding of the 
preparation of the lining of the uterus, the endometrium, for pregnancy. The endometrium is of central importance for successful 
reproduction as it is the site of placental implantation providing the interface between the mother and her baby. Due to the dynamic, 
structural and functional changes the endometrium undergoes throughout the menstrual cycle, it is challenging to study. A major 
advancement is the establishment of 3D organoid models of the human endometrium to study this dynamic tissue in health and 
disease. In this review, we describe the changes that the human endometrium undergoes through the different phases of the 
menstrual cycle in preparation for pregnancy. We discuss defects in the processes of endometrial repair, decidualization and 
acquisition of receptivity that are associated with infertility. Organoids could be utilized to investigate the underlying cellular and 
molecular mechanisms occurring in non-pregnant endometrium and early pregnancy. These studies may lead to therapeutic 
applications that could transform the treatment of reproductive failure.
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Introduction
The World Health Organization describes infertility as 
a ‘disease of the reproductive system defined by the 
failure to achieve a clinical pregnancy after 12 months 
or more of regular unprotected sexual intercourse’ 
(Zegers-Hochschild et al. 2017). It affects around 10% 
of couples of reproductive age and is a consequence 
of female or male reproductive dysfunction and/or low 
embryo quality (Vander Borght & Wyns 2018). In women, 
infertility is classified as primary or secondary, based 
on whether a clinical pregnancy has been previously 
achieved or not (Zegers-Hochschild et al. 2017). Despite 
the advances in assisted reproductive technology (ART), 
infertility is an increasing global public health issue.
Primary infertility of female origin is attributed to 
hormonal, functional or anatomical dysfunction of 
the organs of the reproductive tract. It is a complex 
disorder with a range of contributing factors including 
systemic diseases (diabetes and obesity), environmental 
(endocrine disruptors) and lifestyle (chronic stress 
and delayed childbearing) influences that can affect 
reproductive function (Vander Borght & Wyns 2018). 
Up to 30% of cases of infertility remain unexplained 
(Gelbaya et  al. 2014). Known causes include ovarian 
dysfunction due to premature ovarian insufficiency, poor 
egg quality, polycystic ovary syndrome or fallopian tubal 
blockage, due to damage from infections by Chlamydia 
trachomatis or Neisseria gonorrhoea. Suboptimal 
function of the endometrium, the mucosal lining of the 
uterus, failing to achieve optimal decidualization and 
become receptive are a major cause of primary infertility 
(Cha et al. 2012).
The efficiency of reproduction is lower in humans 
compared to other mammals with only 30% of 
conceptions resulting in a live birth and the majority 
of these losses occurring preclinically (Macklon et  al. 
2002). In ART, methods for the selection of ‘good’ 
embryos prior to transfer include the assessment of 
embryo quality using a grading system that assesses the 
number of cells, fragmentation, speed and symmetry of 
cell division etc. The grading system changes in regard 
to the blastocyst stage. Yet, live birth rates after ART still 
remain low (Gleicher et al. 2019). Ovarian stimulation 
for fresh embryo transfer might impair endometrial 
receptivity and lead to asynchrony between the embryo 
and the endometrium in comparison to the transfer 
of frozen-thawed embryos in a natural cycle which 
results in higher pregnancy rates (Shapiro et al. 2013). 
Although later evidence shows that choosing to transfer 
fresh over frozen embryos and vice versa does not seem 
to significantly change the live birth rates (Wong et al. 
2017), the matter is still under continuous investigation. 
Understanding how the normal endometrium is regulated 
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to interact with the implanting blastocyst is essential to 
define the cellular and molecular mechanisms that are 
altered in a suboptimal endometrium.
The endometrium is a unique mucosa that consists 
of surface epithelium overlying glands with intervening 
stromal and immune cells. All these undergo profound 
phenotypic and transcriptional changes during the 
menstrual cycle in response to ovarian hormones (Garry 
et al. 2009, Munro et al. 2010, Ruiz-Alonso et al. 2012). 
Current knowledge of human endometrial function is 
based on decades of studies using endometrial tissues 
and a range of in vivo and in vitro models. Animal models, 
including non-human primates (monkeys, baboons) 
(Stouffer & Woodruff 2017) and rodents, have provided 
important insights (Fullerton et  al. 2017). However, 
animal studies are labour and cost-intensive and not 
all aspects of human endometrium are recapitulated. 
In vitro models offer a more reproducible alternative. 
Immortalized human endometrial stromal cells have 
been used as reporter lines to study genes involved in 
decidualization (Haller et  al. 2019). Commonly used 
cell lines derived from endometrial adenocarcinomas 
(Ishikawa cells and ECC1) are useful to test the effects 
of oestrogen and progesterone as well as to model the 
luminal epithelium to study implantation in vitro (Mo 
et  al. 2006, Zhang et  al. 2012). These systems suffer 
from a failure to fully reflect the normal physiological 
characteristics of the endometrial epithelium. In addition, 
their 2D nature prevents the cell–cell interactions which 
are characteristic of the complex microenvironment in 
vivo. The establishment of tissue-derived 3D culture 
systems or organoids of the female reproductive tract 
and the placenta offer powerful models for the study of 
these tissues and pregnancy in vitro (Alzamil et al. 2020, 
Heidari-Khoei et al. 2020, Ojosnegros et al. 2021).
The physiology of the endometrium is a determining 
factor in the establishment and maintenance of 
pregnancy as it provides the site of implantation and 
early nutrition to the conceptus during the first few 
weeks of pregnancy (Burton et al. 2002). In this review, 
we describe the functional and morphological changes 
of the endometrium during the menstrual cycle and 
in pregnancy. We discuss how both the endometrial 
physiology and the defects that might arise in distinct 
temporal stages can be studied using organoids. 
Understanding the pathophysiology of infertility due to 
uterine factors using organoid technology will help pave 
the way for the development of strategies to diagnose 
reproductive failure and to design personalized 
therapeutic interventions.
Endometrial organoid culture systems
Endometrial organoids are 3D cultures of the epithelium. 
They can be derived from endometrial tissue from all 
stages of the menstrual cycle, as well as from decidua and 
atrophic endometrium (Fig. 1). Isolated gland fragments 
are embedded into an extracellular matrix (typically the 
commercially available Matrigel) and are grown in a 
chemically-defined medium designed to sustain WNT 
and MAPK signalling whilst inhibiting TGFB and BMP 
pathways (Boretto et  al. 2017, Turco et  al. 2017). The 
organoids are spheroidal structures, around several 
hundred microns in size, with a central lumen that is 
lined by a single columnar epithelium with microvilli 
on their apical surface (Fig. 1). They can be expanded 
long-term (>6 months) without genetic alterations. The 
organoids respond functionally to ovarian hormones 
and placental factors, demonstrated by their expression 
of oestrogen and progesterone receptors and production 
of uterine glandular products (Turco et  al. 2017). The 
ability of the organoids to recapitulate the changes of the 
endometrial epithelium across the menstrual cycle has 
also been demonstrated by comparing the hormonally 
stimulated organoids to endometrial tissue by single-cell 
RNA sequencing (Garcia-Alonso et al. 2021). Organoids 
can also be derived from pathological endometrial tissues 
including endometriosis and endometrial carcinomas 
(Boretto et al. 2019). Collectively, these in vitro models 
allow the study of endometrial physiology and disease 
in a reproducible and standardized manner and are a 
promising tool for the investigation of infertility.
Organoids for the study of the normal endometrium
Menstruation, tissue repair and regeneration
During the menstrual cycle, which in humans last 26–32 
days, the endometrium undergoes shedding, repair, 
regeneration and remodelling to provide a ‘fertile soil’ for 
implantation of the embryo (Evans et al. 2016). Because 
of this extraordinary plasticity, it has been challenging to 
study as access to samples throughout the cycle is needed, 
together with models that can recapitulate this process. 
Menstruation, the shedding of the functional layer of 
the endometrium (days 1–5), occurs in the absence of 
conception and embryonic implantation. The trigger 
for menstruation is the regression of the corpus luteum 
leading to a reduction in levels of ovarian hormones, 
oestrogen and progesterone (Fig. 2). Vasoconstriction 
of uterine blood vessels and breakdown of the stratum 
functionalis then follow (Maybin & Critchley 2015). To 
ensure tissue integrity, endometrial repair starts almost 
immediately after the onset of menstruation (days 2–5) 
along with re-epithelization and revascularization (Fig. 
2) (Ludwig & Spornitz 1991). Although oestrogen is not 
essential for endometrial repair, it is required for efficient 
regeneration during the proliferative or follicular phase 
of the menstrual cycle (days 6–13) (Fig. 2). Oestrogen 
receptor (ESR1) expression is highest during this phase 
in both the epithelial and stromal compartments where 
maximal levels of mitoses are seen (Lessey et al. 1988).
Our understanding of the mechanisms that regulate the 
breakdown and regeneration of the endometrium each 
month is surprisingly limited. During the first half of the 
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cycle, epithelial and stromal cells proliferate. Although 
there is a consensus about stem/progenitor cells with 
clonogenic properties being responsible for endometrial 
regeneration, their exact identity and location have been 
controversial. Putative progenitors include epithelial 
cells in basal glands (SSEA-1+, SOX9+, CDH2), epithelial 
cells at the surface epithelium (LGR5+), stem cells likely 
to be pericytes (SUSD2+, CD146+CD140B), stromal 
fibroblasts from menstrual blood, endometrial and 
decidual side-population cells (CD31+ endothelial cells 
and CD140B CD146+ pericytes) and bone marrow-
derived cells (Gargett et al. 2016, Nguyen et al. 2017, 
Tempest et al. 2018, Hapangama et al. 2019). Thus, this 
central question of which cells drive the regenerative 
process remains unanswered.
Endometrial organoids proliferate in response to 
signalling cues provided by the culture medium and 
differentiate upon treatment with hormones (Fig. 1). 
Their clonal ability and potential to grow long-term 
make them a unique tool to address the identity of 
epithelial progenitors and to mimic/reproduce changes 
during the menstrual cycle in vitro. Whether it is the 
withdrawal of the hormones from the culture medium 
or/and mechanical disruption (passaging) that facilitates 
their subsequent regrowth has not been addressed. 
Transcriptomic approaches allow the generation of 
reference datasets to identify the different epithelial 
populations in vivo and infer their potential roles in the 
function of the endometrium. For example, single-cell 
RNA sequencing analysis of organoids has identified a 
putative stem cell population that decreased when they 
were treated with oestrogen, progesterone and cyclic 
AMP (cAMP) (Fitzgerald et al. 2019). The dynamics of 
SOX9 and LGR5 expression in the human uterus during 
the menstrual cycle was refined by the generation 
of a reference map using single-cell and spatial 
transcriptomics (Garcia-Alonso et  al. 2021). This has 
revealed that SOX9+ cells segregate into a non-cycling 
LGR5+ population at the luminal epithelium and a LGR5− 
population in the deeper glands. To investigate whether 
these markers are specific for cells with stem cell/
progenitor potential, reporter organoid lines for these 
genes could be generated using gene editing approaches. 
For instance, genes of interest linked to a fluorescent tag 
could be introduced (knocked-in) into single cells using 
the CRISPR/Cas9 technology (Artegiani et  al. 2020). 
These genetically modified organoid lines would allow 
the investigation of pathways regulating proliferation/
regeneration (Fig. 3). Such studies will help identify 
progenitors of the endometrial epithelium and how their 
altered behaviour may be involved in disorders, such 
as endometriosis affecting fertility. For example, it has 
been shown that in women with endometriosis, there is 
an increase in the number of SOX9+ SSEA1+ cells in the 
functional layer that can generate ectopic endometriotic 
lesions in 3D culture (Hapangama et al. 2019).
Figure 1 Organoids of the human endometrium. Organoids can be derived from tissue biopsies from non-pregnant women in the proliferative or 
secretory phase of the menstrual cycle or from pregnant and postmenopausal women. The sample is minced mechanically and enzymatically to 
obtain epithelial isolates which are resuspended in an extracellular matrix (Matrigel) to allow self-organization of the organoids into a cystic 
structure formed by columnar epithelial cells lining a central lumen. They can be propagated long-term in a chemically defined medium 
(Expansion medium, ExM) containing nicotinamide, supplements (N2, B27), activators of WNT signalling (RSPO1 and CHIR99021), growth 
factors (EGF, HGF, and FGF10) and inhibitors of TGFB and BMP signalling pathways (A83-01 and Noggin, respectively). They recapitulate the 
morphological, molecular and functional features of endometrial glands in vivo and respond to steroid hormones, oestrogen and progesterone. 
To induce differentiation, they are primed with oestrogen for 2 days and then treated with a combination of oestrogen, progesterone, prolactin 
and cAMP for another 4 days. Brightfield images depict morphological changes in an organoid culture before (day 0), during (day 2) and after 
(day 6) their differentiation with hormones. Organoids with thicker epithelia and secretions in the lumen are visible after full hormonal 
stimulation. Organoids can also be derived from pathological endometrium including endometriosis, endometrial hyperplasia and cancer.
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Pre-receptive and receptive phases
Upon pregnancy, the endometrium continues 
its differentiation and transforms into decidua. 
Decidualization in humans (and other species that 
menstruate) occurs spontaneously, unlike in mice. 
Following ovulation (day 14), the endometrium undergoes 
substantial remodelling of all cellular elements to become 
receptive for implantation in the mid-secretory or luteal 
phase (Fig. 2). Initially, increasing levels of progesterone 
prime the endometrium to enter a pre-receptive state 
(days 15–19). Although the luminal epithelium is still 
refractive to implantation, the glandular epithelium 
becomes increasingly columnar with the appearance of 
characteristic subnuclear vacuoles. As decidualization 
proceeds, the uterine glands increase their production of 
‘uterine milk’ containing components like osteopontin, 
glycodelin and EGF (Burton et  al. 2020). The stromal 
cells encircling spiral arteries enlarge to acquire a 
secretory phenotype and produce basement membrane 
components. As the secretory phase progresses, there is 
an increased production of prolactin (PRL) and insulin-
like growth factor-binding protein 1 (IGFBP1) (Massimiani 
et al. 2019). In order to facilitate implantation, the luminal 
epithelium also undergoes changes to become adhesive. 
Pinopodes appear along with the expression of specific 
integrins, glycoproteins and cadherins (Creus et al. 2002).
The window of implantation (WOI) (days 20–24) marks 
the phase during which the endometrium is receptive 
and the implantation of the blastocyst can occur (Fig. 2). 
Although there are several assays for receptivity (e.g. 
endometrial thickness, volume, pattern, blood flow), 
their accuracy is questionable and, thus, their clinical use 
is poor (Craciunas et al. 2019). On the contrary, genetic 
signatures and molecular biomarkers of receptivity are 
more promising. An endometrial receptivity array can 
be used to classify endometrial biopsies according to 
their transcriptomic profile, based on which women 
can then undergo personalized embryo transfer (Díaz-
Gimeno et  al. 2011). This allows the proper timing of 
the transfer according to the receptive status of the 
endometrium and evidence shows that it can efficiently 
predict pregnancy rates (Díaz-Gimeno et  al. 2017). 
Now, the transcriptomic transition of the endometrium 
across stages of the menstrual cycle has been refined 
accounting for the different cell types using next-
Figure 2 Endometrial changes across the menstrual cycle. The endometrium undergoes significant changes during the course of the menstrual 
cycle which in humans lasts approximately 28 days. Menstruation is the first phase of the cycle, during which the spiral arteries (AR) contract, 
resulting in ischaemia and shedding of the functional layer of the tissue, including both epithelial and stromal compartments. Repair starts 
almost simultaneously. In the proliferative phase, regeneration is driven by rising levels of oestrogen (E2) from the ovarian follicle that stimulate 
proliferation of epithelial, stromal and endothelial cells. Numerous developing glands of tortuous morphology are characteristic of the 
proliferative phase. At midcycle, the surge of gonadotropins, follicle-stimulating hormone (FSH) and luteinizing hormone (LH) released from the 
anterior pituitary induce ovulation. The release of the oocyte marks the beginning of the secretory phase during which the corpus luteum forms 
from the ruptured ovarian follicle and secretes progesterone (P4), the hormone responsible for preparation of the uterine environment for 
pregnancy. During this phase, the endometrial glands (GL) become cork-screw shaped and twisted whilst their secretory potential maximizes. 
The stromal cells (SC) undergo concomitant changes differentiating intopre-decidualized stromal first (PDS) and then decidualized stromal (DS) 
cells. Rising levels of E2 in combination with P4 mark the window of implantation (WOI), a limited time frame during which the implantation 
happens. The blastocyst attaches to the endometrium through projections (pinopodes) that form at the apical side of the luminal epithelium (LE). 
In the absence of a blastocyst, the WOI spontaneously becomes refractory due to the rapid decrease in P4 levels leading to menstruation, thus 
resetting the cycle. Conversely, an implanting blastocyst secretes chorionic gonadotropin (CG) to maintain the secretion of P4 from the corpus 
luteum, thereby supporting pregnancy.
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generation sequencing technologies (Wang et al. 2020). 
Abrupt and discontinuous transcriptional activation of 
the endometrial epithelium followed by a continuous 
transition of the fibroblasts could be used to predict the 
start of the WOI more accurately (Wang et al. 2020).
Decidualization is mediated by hormonal signalling 
through oestrogen and progesterone. Oestrogen acts 
through the oestrogen receptor α (ESR1) to enhance 
the expression of progesterone receptor (PGR) allowing 
the endometrium to respond to the elevated levels of 
Figure 3 Applications of endometrial organoids in infertility. Organoids can be derived from biopsies of normal or pathological endometrium 
(endometriosis or carcinoma). Organoids from women suffering from other uterine disorders such as Asherman’s syndrome (AS), adenomyosis or 
other disorders that affect the endometrium indirectly, like polycystic ovary syndrome (PCOS), are yet to be established. The organoids consist of 
epithelial cells but isolation of stromal cells from the same biopsies will allow the creation of complex co-culture systems that combine both 
cell types facilitating the study of decidualization. Exposure of the organoids to commensal or pathogenic microorganisms (viruses, bacteria) 
will reveal how infection affects epithelial integrity and fertility. Implementation of bioengineering technologies for the combination of 
organoids from reproductive organs (ovaries, endometrium) and other organs/tissues- (pancreas, adipose tissue, capillaries) on-a-chip will lead 
to the creation of more dynamic in vitro models. Endometrial organoids could be co-cultured with trophoblast organoids derived from the 
first-trimester placentas, to study the signals that mediate the interaction between the fetus and the mother. Addition of uterine natural killer (NK) 
cells will help elucidate how maternal immune cells affect trophoblast proliferation and differentiation and shed light into obstetric disorders 
that arise due to placentation failure. Another application of endometrial organoids is their use in single cell and spatial transcriptomic 
technologies for the identification and localization of progenitor cells. Potentially identified markers of progenitor cells could then be used to 
genetically edit organoids to create reporter lines and monitor their expression in different conditions. In the future, organoids could provide an 
alternative therapy for the replacement of scarred endometrium in women with AS. Women suffering from endometriosis could also benefit from 
replacement of the progesterone-resistant endometrium with organoids, genetically manipulated to express progesterone receptors and thus 
respond to progesterone. Translational applications of the endometrial organoids include drug testing; testing the dosage and response to 
oestrogen and progesterone to offer tailored hormonal treatment for women prior to in vitro fertilization (IVF).
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progesterone during the secretory phase (Massimiani 
et al. 2019) (Fig. 4). PGR is expressed by both epithelial 
and stromal cells (Snijders  et al. 1992) and is activated 
by progesterone to initiate decidualization through 
epithelial–stromal cell interactions. Progesterone-
regulated transcription factors (CCAAT/Enhancer 
Binding Protein-β and the Homeobox family proteins 
A10) and progesterone mediators (Bone Morphogenetic 
Protein-2, Indian Hedgehog, Forkhead Box O1, Heart 
and Neural Crest Derivatives expressed 2) are crucial for 
decidualization (Massimiani et al. 2019) (Fig. 4).
Endometrial organoids can be used to study 
decidualization. When stimulated with oestrogen 
followed by progesterone, they upregulate ESR1 and 
PGR and secrete uterine milk products including 
glycodelin and osteopontin accompanied by 
transcriptomic changes with downregulation of putative 
stem cell markers found in other epithelia (SOX9, 
PROM1, AXIN2 and LRIG1) (Turco et al. 2017). This will 
facilitate the study of epithelial-specific responses to 
ovarian hormones and, together with CRISPR/Cas gene-
editing technologies, the signalling cascades could 
then be examined in detail. For example, oestrogen 
and progesterone receptors could be knocked-out 
either separately or in combination in single cells from 
established endometrial organoids. These would then 
be clonally expanded into knock-out lines to assess the 
exact role of hormone signalling in differentiation and 
acquisition of a secretory glandular profile. CRISPR/
Cas gene targeting has been successfully achieved 
in different organoid systems (Hendriks et  al. 2020). 
Though similar approaches have been employed for 
targeting endometrial cell lines (Kinnear et  al. 2019, 
Wang et  al. 2019), this has not yet been reported for 
endometrial organoids. Technical challenges include 
the requirement of high cell numbers and optimal 
method of delivery of targeting reagents. Using these 
approaches, important questions like how progesterone 
resistance in patients with endometriosis could 
negatively impact decidualization and successful 
preparation for pregnancy could be addressed. There 
are also new methods to co-culture endometrial 
organoids with stromal cells in a collagen scaffold 
providing opportunities for in vitro modelling of the 
endometrium to study stromal–epithelial interactions 
driving decidualization (Abbas et al. 2020) (Fig. 3).
Implantation and post-receptive phase
In the absence of a viable embryo, the WOI closes and the 
endometrium transits into a non-receptive phase (days 
24–28). The corpus luteum involutes with decreasing 
progesterone levels resulting in menstruation (Fig. 2). 
The release of chorionic gonadotropin from a blastocyst 
during the WOI, on the other hand, aids the maintenance 
of the corpus luteum and decidualization continues (Fig. 
2). The trophectoderm surrounding the inner cell mass 
makes contact with the luminal surface of the receptive 
endometrium through a finely regulated process of 
apposition, attachment and implantation. Attachment 
of the blastocyst reinforces decidualization of the 
stromal compartment through the secretion of signalling 
molecules and, in response, the latter signals back to 
support blastocyst survival (Fig. 4). These interactions 
are fundamental for the proper establishment of the 
maternal–fetal interface. However, the characteristics of 
a receptive decidualized endometrium and the nature 
of the signals between decidua and embryo that support 
pregnancy remain elusive.
In humans, implantation is particularly intrusive and 
the trophectoderm rapidly invades the endometrial 
stroma once it has breached the luminal epithelium. 
In comparison to other species, the human blastocyst 
burrows in the surface epithelium, which grows 
over it and surrounds it. Specialized placental cells, 
extravillous trophoblast, invade the uterine spiral 
arteries in order to establish the blood supply for the 
fetal–placental unit (Turco & Moffett 2019). A balanced 
invasion of the trophoblast into the decidua is essential 
for a successful pregnancy; too shallow invasion results 
in insufficient spiral artery remodelling resulting in pre-
eclampsia, miscarriage or still-birth whilst too deep 
invasion results in the accreta spectrum (Jauniaux 
et  al. 2018). The maternal–fetal interactions can now 
be investigated using human trophoblast organoids 
from the early human placenta (Haider et  al. 2018, 
Turco et  al. 2018) that retain in vivo features of early 
trophoblast and secrete placental-specific peptides and 
hormones, including chorionic gonadotropin (Turco 
et al. 2018). Trophoblast organoids are a powerful tool 
for studying the development of the human placenta 
and its interactions with the decidua as they can also 
differentiate into invading extravillous trophoblast cells 
(Turco et al. 2018).
Uterine natural killer (uNK) cells make up ~70% of 
CD45+ leukocytes cells within the decidua (King et al. 
1989, Vento-Tormo et  al. 2018). uNK cells proliferate 
in situ in the secretory phase under the influence 
of progesterone when other cellular elements are 
differentiating and during pregnancy, they are found at 
the site of placentation close to infiltrating trophoblast 
cells and around the maternal spiral arteries (Moffett 
& Shreeve 2015). The exact functions of uNK cells 
are still unknown but genetic studies of pre-eclampsia 
suggest that they are likely to regulate the invasion of 
trophoblast cells maintaining the balance between 
excessive and deficient trophoblast intrusion (Moffett 
& Colucci 2014). This fundamental question can be 
addressed by co-culturing uNK cells with trophoblast 
organoids to identify factors secreted by uNK cells 
affecting the growth, differentiation and potential for 
invasion of trophoblast (Fig. 3). uNK cells are never in 
contact with the inner cell mass or developing embryo 
and cannot cause ‘fetal rejection’. There is also no 
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evidence that uNK cells are responsible for reproductive 
failure in women with failed IVF and treatments aiming 
to ‘suppress’ uNK cells are not without risk to healthy 
women (Moffett & Shreeve 2015). Current evidence 
indicates that recognition of fetal trophoblast cells 
activates the maternal NK cells, through certain ligand-
receptor combinations, which could then enhance 
placentation (Xiong et al. 2013).
Besides organoids, culture methods for human 
embryos, together with transcriptomic and 
bioengineering technologies, provide additional 
experimental approaches for the study of early human 
Figure 4 Signalling pathways crucial for decidualization and implantation. Decidualization and implantation rely on continuous cellular 
interactions between epithelial cells at the surface and in glands, stromal cells and the incoming blastocyst (top left panel). Progesterone (PG) 
mediates its function through progesterone receptor (PGR) whose expression is induced by the action of oestrogen (E2) through oestrogen 
receptor (ESR1), and in turn, PGR inhibits ESR to create a negative feedback loop system. Upon binding of P4, PGR acts as a transcription factor 
which translocates to the nucleus to mediate genomic actions. Homeobox A10 (HOXA10), Forkhead Box O1 (FOXO1), heart and neural crest 
derivatives expressed 2 (HAND2) and CCAAT/Enhancer Binding Protein-β (C/EBPβ) are transcription factors that are regulated by progesterone 
and are indispensable for decidualization. FK506 binding protein prolyl isomerase 4 (FKBP52) is a PGR chaperon that promotes the activity of 
the receptor during decidualization. PGR at the surface of the cells can also trigger downstream molecules to activate the extracellular 
signal-regulated kinase/mitogen-activated protein kinase (ERK/MAPK) and Protein Kinase B (AKT) pathways and, thus, mediate non-genomic 
actions (top right panel). Progesterone activates the expression of Indian hedgehog (IHH) in the epithelium, a morphogen that promotes the 
decidualization of stromal cells via activation of chicken ovalbumin upstream promoter-transcription factor II (COUPTFII) that subsequently 
regulates the expression of bone morphogenetic protein 2 (BMP2). BMP2 is a morphogen of the TGFB pathway, acting through Wingless 4 
(WNT4). TGFB1 is another member of the TGFβ pathway secreted by epithelial cells. Subsequently, stromal cells are stimulated to produce 
prolactin (PRL), insulin-like growth factor-binding protein 1 (IGFBP1) and interleukin 11 (IL-11), classic markers of decidualization (bottom left 
panel). Upon attachment to the uterus, trophoblast secretes hormones, chorionic gonadotropin (CG) and placental lactogen (PL), as well as 
cytokines like interleukin 1β (IL1B). In turn, epithelial glands secrete uterine milk, a cocktail of glycoproteins (glycodelin-A, osteopontin, 
uteroglobin), glycogen, lipids, as well as, growth factors (leukaemia inhibitory factor (LIF), epidermal growth factor (EGF), vascular endothelial 
growth factor (VEGF). In addition, IL1B and CG reinforce decidualization by promoting cyclooxygenase-2 (COX2) and prostaglandin E synthase 
(PGE2) expression by epithelial cells and subsequently augmenting cAMP production from stromal cells. IL1β also acts on maternal stromal cells 
to promote expression of αvβ3 integrin, matrix metalloproteinases (MMPs) and C-X-C motif chemokine 10 (CXCL10) which are necessary for 
tissue remodelling and angiogenesis to support trophoblast invasion (bottom right panel). SC, stromal cell; PDS, pre-decidualized stromal cell; 
DS, decidualized stromal cell; SE, secretory epithelial cell.
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development (Deglincerti et  al. 2016, Shahbazi et  al. 
2016, Cermola et  al. 2021). Stem cell-derived pre-
implantation embryos ‘blastoids’ could provide a 
solution for overcoming the ethical difficulties of 
using human embryos (Rivron et al. 2018, Zheng et al. 
2019). Endometrial models could then be co-cultured 
with embryos/blastoids and trophoblast organoids to 
create an implantation model (Ban et  al. 2020) (Fig. 
3). Although there are many challenges in combining 
different cell types, such a model would also offer a 
unique opportunity to explore the secretory profile of 
the endometrium during pregnancy and its effect on the 
trophoblast. The aim is to identify markers of endometrial 
receptivity or critical regulators of the maternal–fetal 
cross-talk for the development of predictive tests and 
therapeutic interventions for tackling compromised 
fertility related to poor endometrial receptivity.
Investigation of abnormal endometrial function and 
infertility using organoids
Defective endometrial regeneration and proliferation
Altered function or regulation of endometrial progenitors 
and their niche are likely to be responsible for some 
endometrial disorders. Dysregulated proliferation is 
seen in endometriosis, hyperplasia and carcinomas 
or during the insufficient growth of the endometrium 
(Gargett et  al. 2016). Although controversy exists on 
the clinical significance of reduced thickness in women 
undergoing ART, a thin endometrium unresponsive to 
oestrogen stimulation has been associated with failure 
of implantation. A recent retrospective study shows that 
decreased endometrial thickness (<7 mm) on the day 
of ovulation, but not on the day of embryo transfer, is 
associated with low pregnancy rates (Nishihara et  al. 
2020). Even in women without ovarian stimulation, a thin 
endometrium may be considered a negative prognostic 
factor for pregnancy (von Wolff et  al. 2018). Several 
factors could be responsible for a thin endometrium: 
low oestrogen levels and inadequate blood flow due 
to lifestyle factors (increased BMI, birth control pills, 
ovulation stimulating drugs).
Canonical Wnt/β-catenin signalling is essential for the 
development of the human uterus (Habiba et al. 2021). 
The WNT pathway also plays a role in adulthood as it 
regulates endometrial cell proliferation and homeostasis 
after menstruation. Perturbations in WNT signalling 
have been associated with infertility (Sonderegger et al. 
2010). Enhancement of the activity of WNT pathway 
by oestrogen and inhibition by progesterone fine tune 
its action and prevent neoplastic transformation (Wang 
et  al. 2010). This effect of WNT signalling is seen in 
organoids as the withdrawal of R-spondin, a growth 
factor that enhances this pathway, from the culture 
medium causes a reduction in size and number of 
organoids (Boretto et al. 2017, Turco et al. 2017). WNT 
ligands (WNT3A, WNT4 etc.) but not R-spondins are 
expressed by organoids explaining the requirement for 
external addition of R-spondin but not WNT3A (Boretto 
et al. 2017). Components of the WNT pathway, including 
its target genes, have been linked to endometriosis and 
endometrial cancer (Boretto et al. 2019). The growth of 
organoids from ectopic endometriotic tissue is enhanced 
by R-spondin but reduced when the WNT pathway is 
inhibited. Transcriptomic analysis of ectopic organoids 
further highlights the expression of WNT pathway genes 
(CTNNA2, LEF1, WNT11). Organoids from endometrial 
low-grade tumours also highly express WNT target 
genes (AXIN2, LEF1, CMYC, TCF4, LGR6) (Boretto et al. 
2019). Furthermore, integration of scRNAseq data of the 
human uterus with genome-wide association studies 
(GWAS) shows endometrial fibroblasts expressing WNT 
ligands involved in endometriosis (WNT4, RSPO3) 
and endometrial cancer (RSPO1) which could bind 
WNT receptors in epithelial cells (Garcia-Alonso et al. 
2021). Because of its possible implication in altered 
proliferative and regenerative capacity in i women with 
unexplained infertility, Wnt signalling could be studied 
in organoids derived from these women. Another 
interesting application would be to prolong exposure 
of the organoids to oestrogen and investigate changes 
in WNT components and test whether a hyperplastic 
profile emerges.
Disorders affecting endometrial function and 
decidualization
Defective decidualization impedes the ability of the 
endometrium to receive and support the survival of the 
embryo. Apart from infertility, it has been implicated 
in pregnancy complications including pre-eclampsia, 
fetal growth restriction and preterm birth (Cha et  al. 
2012, Conrad et  al. 2017). Decidualization defects 
are also seen in disorders that lead to hormonal and 
metabolic dysfunction of the endometrium, including 
endometriosis, adenomyosis, and polycystic ovary 
syndrome (PCOS). Endometriosis is a complex disease 
affecting ~10% of women of reproductive age, 
characterized by endometrial deposits outside the 
uterine cavity, including pelvic peritoneal surfaces, 
ovaries, ligaments, bladder or the bowel (Holoch 
& Lessey 2010). Painful periods and intercourse, 
chronic pelvic pain and abnormal bleeding are the 
most common symptoms. Around 50% of women 
with endometriosis, in particular those <35 years, 
have fertility issues (Holoch & Lessey 2010). GWAS 
meta-analysis studies identified susceptible genes for 
endometriosis including those involved in oestrogen-
regulated pathways (OSR1, GREB1) (Sapkota et  al. 
2017). This reinforces the importance of oestrogen 
dominance in endometriosis and, hence, increased 
proliferation (Marquardt et  al. 2019). Progesterone 
resistance, the inability to respond to progesterone, 
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has been commonly described in both ectopic and 
eutopic endometrium in endometriosis, attributed 
to dysfunction of the PGR itself or its downstream 
mediators (Marquardt et al. 2019). Failure to respond 
properly to progesterone not only results in defective 
decidualization but also in growth of lesions due to a 
failure to counteract oestrogen-induced proliferation 
(Marquardt et al. 2019). A recent study has shed further 
mechanistic insight that may question progesterone 
‘resistance’ (Houshdaran et  al. 2020). Although 
endometrial stromal fibroblasts from women with 
endometriosis do not fully decidualize, they respond to 
progesterone differently from normal cells (Houshdaran 
et al. 2020).
Altered progesterone response is not restricted to 
endometriosis and may play a role in other endometrial 
disorders. Adenomyosis, characterized by the presence 
of endometrial glands within the myometrium, is a 
poorly understood disease. It is commonly linked 
to endometriosis with the key characteristic being 
hyperestrogenism, which may result in progesterone 
resistance in the eutopic endometrium (Benagiano 
et  al. 2014). Polycystic ovary syndrome (PCOS) could 
also affect the endometrium indirectly. Anovulatory 
cycles are a major feature of PCOS meaning that the 
corpus luteum does not form and progesterone is 
absent. The expression of PGR is altered and genetic 
analyses revealed impaired response to progesterone 
in women with PCOS. However, the exact molecular 
mechanism underlying progesterone resistance in PCOS 
is not understood (Li et al. 2014). Hyperandrogenism is 
likely another feature of PCOS contributing to impaired 
endometrial function (Simitsidellis et al. 2018). Elevated 
androgens result in delayed decidualization of stromal 
cells which produce limited amounts of prolactin 
in vitro (Younas et  al. 2019). As a consequence, the 
endometrium would fail to acquire a receptive state 
in time to support implantation. Understanding the 
relationship between altered hormonal responses and 
impaired decidualization is crucial for assessing the 
receptive capacity of an abnormal endometrium.
Organoids have been generated from eutopic and 
ectopic endometrium of women with endometriosis. 
They recapitulate the morphological and molecular 
characteristics of the native endometriotic lesions and 
reproduce the disease when injected into the peritoneal 
cavity of mice. In addition, glycodelin (PAEP), a 
progesterone-regulated gene, was downregulated in the 
organoids at different stages of endometriosis. On the 
contrary, SOX9 was upregulated further supporting the 
hypothesis that an altered progesterone response and 
enhanced proliferation is driving endometriosis (Boretto 
et  al. 2019). In future, establishment of endometrial 
organoids from patients with adenomyosis or PCOS 
will allow further investigation on how receptivity is 
regulated (Fig. 3) and lead to appropriate therapies to 
enhance fertility in women with defective endometrium.
An interesting perspective has highlighted variable 
methylation patterns of the Human Homeobox (HOX) 
genes and their cofactors between eutopic and ectopic 
organoids and tissues from women with endometriosis 
(Esfandiari et al. 2021). These epigenetic changes could 
be used as a prognostic factor for endometriosis. More 
specifically, organoids derived from girls likely to inherit 
a harmful epigenetic trait from their mothers suffering 
from endometriosis could be used to predict their 
chances of developing endometriosis (Koninckx et  al. 
2021).
Lifestyle and environmental factors affecting 
endometrial function
Delayed maternal age and high BMI are associated 
with sub/infertility (Vander Borght & Wyns 2018). 
Spontaneous abortions in the first trimester of pregnancy 
are common in older women due to chromosome 
mis-segregations in the oocyte leading to karyotypic 
imbalances in the offspring. In the absence of any 
karyotypic abnormality, advanced maternal age still 
contributes to pregnancy complications, namely fetal 
growth restriction, pre-eclampsia and stillbirth due to 
disordered embryo–maternal interactions. Aged mice 
have a reduced number of NK and dendritic cells 
which could have a negative effect on placentation, 
whilst stromal cells present a blunted response to 
decidualization signals (Woods et al. 2017). Apart from 
poor oocytes, the mechanisms by which increased 
maternal age impede endometrial function and normal 
pregnancy are unclear. The influence of obesity, along 
with other lifestyle factors (smoking, lack of exercise, 
stress, drugs, environmental pollutants), on fertility 
is an important current discussion (Silvestris et  al. 
2018). Obese mice have smaller implantation sites and 
deciduomas, whilst in vitro human endometrial stromal 
cells cultured in the presence of fatty acids demonstrate 
lower expression of decidualization markers (PRL, 
IGFBP1) (Rhee et  al. 2016). Given that many aspects 
of obesity could contribute to decidualization defects 
and that the number of human samples was small in 
this study, further research is required to underpin the 
molecular mechanisms that may lead to decidualization 
defects and, thus, poor receptivity in obese women.
Endometrial organoids can be derived and biobanked 
from fresh biopsies of infertile women who undergo 
IVF and monitored until a clinical pregnancy occurs. 
Organoids can also be established from frozen biopsies 
from infertile women, thus facilitating sample collection 
(Bui et  al. 2020). By stratifying the patient samples 
according to maternal age, BMI and pregnancy outcome, 
specific comparisons to investigate organoid function 
could be done. A focus on organoids from women 
with BMI ≥ 30 or ≥ 40 years of age with implantation 
failure for whom dysfunctional endometrium might be 
a high-risk factor would be of great interest. Analysing 
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the differences in their genetic signature or secretome 
profiles will allow identification of negative indicators 
of pregnancy success. Understanding how maternal 
age and bodyweight limit reproductive fitness will help 
clinicians offer specialized advice or even appropriate 
medical treatment to enhance the chances for a 
successful and healthy pregnancy.
The function of the female reproductive system is 
controlled by hormones released by the hypothalamus 
(GnRH), the anterior pituitary gland (FSH, LH, PRL) 
and the ovaries (oestrogen, progesterone). Endocrine-
disrupting chemicals (pesticides, heavy metals, plasticizer 
alternatives, parabens) are commonly used in Western 
societies with concerns about their impact on female 
infertility (Rattan et  al. 2017). REACH (Registration, 
Evaluation, Authorisation and Restriction of Chemicals), 
the European Union regulation which addresses the 
potential impact of chemical substances, has banished 
the use of di-(2-ethylhexyl) phthalate (DEHP), a 
plasticizer alternative, on grounds of causing toxicity. 
However, studies on how these chemicals disrupt female 
reproductive function are scarce. Organoids could 
be utilized to explore whether endocrine disruptors, 
highlighted by REACH as ‘high-concern substances’, 
cause endometrial toxicity using a reproductive toxicity 
reporter system. Recently, a dual reproductive organ-on-
a-chip recapitulating the endocrine crosstalk between 
the ovary and the endometrium has been developed (Park 
et al. 2020). Although the study uses 2D cell cultures, 
this technology has great potential and incorporation 
of endometrial and ovarian organoid cultures would 
enable the accurate evaluation of the effect of various 
chemical substances on endocrine and, consequently, 
uterine function.
Endometrium and its microbiome
Although the endometrium was always considered 
a ‘sterile’ environment, it is now accepted that 
commensals are present and pathogens can ascend 
through the cervix causing endometritis (Perez-Muñoz 
et  al. 2017). Next-generation sequencing techniques 
revealed a microbiome signature (>90% Lactobacillus 
spp.) in the uterine mucosa that does not respond 
to hormonal changes and remains stable during the 
menstrual cycle (Moreno et al. 2016). It is possible that 
alterations in the microbiome resulting in inflammation 
could affect decidualization by activation of Toll-like 
receptors in epithelial or stromal cells (Benner et  al. 
2018). Furthermore, changes in the species (non-
Lactobacillus dominated microbiota) in the receptive 
endometrium has been associated with a significant 
decrease in implantation and increased miscarriage in 
women who undergo IVF (Moreno et al. 2016), although 
the mechanisms responsible remain to be explored.
Colonization of the uterine tract with pathogenic 
bacteria or viruses leads to endometritis, a cause of 
infertility (Puente et  al. 2020). Endometritis affects 
decidualization of human endometrial stromal cells by 
modifying the expression of ESRs and PGRs (Wu et al. 
2017) but this study only had low sample numbers and 
needs further confirmation. 3D cultures of an endometrial 
epithelial cell line showed that infection with pathogenic 
N. gonorrhoeae induced proinflammatory mediators and 
morphological changes to the host cells (Łaniewski et al. 
2017). We envisage that similar approaches could be 
employed with endometrial organoids to understand the 
mechanisms by which commensals and pathogens affect 
glandular integrity and differentiation and, ultimately, 
how this alters endometrial receptivity (Fig. 3). Indeed, 
murine endometrial organoids have been infected 
with Chlamydia trachomatis after being mechanically 
fragmented (Bishop et  al. 2020), while more recently 
Chlamydia strains have directly been microinjected at 
the apical surface of the polarized epithelium (Dolat & 
Valdivia 2021). The infection resulted in reorganization 
of the cytoskeleton and the Golgi apparatus as well as 
disordered the cell junctions. Furthermore, the infected 
organoids were co-cultured with bone marrow-derived 
neutrophils, which could infiltrate the extracellular 
matrix (Matrigel) and migrate towards the infected 
organoids (Dolat & Valdivia 2021). Similar approaches 
could now be employed to infect endometrial organoids 
of human origin and test the efficacy of antimicrobial 
drugs in an effort to provide personalized therapy for 
women who suffer from endometritis.
Endometrial organoids-on-a-chip
A major step forward in the generation of more complex 
in vitro models of reproductive tissues has been the 
application of microfluidic technologies. A ‘multi-organ’ 
microfluidic system that recapitulates aspects of the 
human menstrual cycle over 28 days by incorporating 
explants of the murine ovary, human fallopian tube, 
uterus, cervix and liver with steroid hormones released 
from ovarian follicles was developed (Xiao et al. 2017). 
Another approach is a dual reproductive organ-on-
a-chip system that allows the bidirectional crosstalk 
between the ovaries and the endometrium. This model 
recapitulates the multicellular complexity of both 
tissues as the ovarian compartment contains granulosa 
and theca cells, whilst the endometrial compartment 
includes fibroblasts, vascular epithelial cells, immune 
cells, and endometrial stem cells (Park et  al. 2020). 
Replacing tissue explants and 2D cell cultures with 
organoids would significantly enhance the accuracy 
of such multi-organ systems. They would be useful to 
investigate epithelial–stromal–immune cell interactions 
during different stages of the menstrual cycle and 
pregnancy and the effect of endocrine disruptors or 
pathogens and microbiota on reproductive function. 
Another exciting prospective in the context of obesity 
and diabetes would be a combination of organoids from 
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the female reproductive tract (ovaries, endometrium) 
with those from adipose and pancreatic tissues to 
model systemic interactions and investigate how when 
perturbed, may affect fertility (Fig. 3).
Translational applications of endometrial organoids 
for the treatment of infertility
Personalized medicine
Despite numerous protocols for exogenous administration 
of oestrogen and progesterone to prepare the endometrium 
in women undergoing IVF, clinical pregnancy is not 
always guaranteed. There is considerable debate about 
the type, dosage and timing of hormonal supplementation 
(Nawroth & Ludwig 2005). Whilst oestrogen is crucial for 
the duration of the WOI, administration of high doses 
results in implantation failure in mice (Ma et al. 2003) and 
increases the risk of ovarian hyperstimulation syndrome 
(Aboulghar 2003). Likewise, the administration of 
progesterone in high concentrations for the treatment of 
luteal phase deficiency has a detrimental effect on uterine 
receptivity and decidualization, demonstrated in mice in 
vivo and immortalized human endometrial stromal cells 
in vitro (Liang et al. 2018).
Endometrial function varies considerably in women. 
Endometrial organoids offer a unique opportunity to 
provide personalized advice prior to hormonal treatment 
allowing the prevention of associated side effects like 
ovarian hyperstimulation syndrome. Organoids could be 
derived from endometrial biopsies of women undergoing 
IVF and exposed to different dose combinations of 
oestrogen and progesterone to evaluate proliferation and 
differentiation rates. Investigating the expression of ESR 
and PGR in the organoid cultures would also be useful 
for predicting the ability of the endometrium to acquire a 
receptive state in response to progesterone (Fig. 3).
Pharmacological therapies for endometriosis aim to 
suppress endogenous oestrogen production (aromatase 
inhibitors, gonadotropin-releasing hormone agonists/
antagonists, selective oestrogen receptor modulators) 
and the activation of progesterone receptors (natural 
metabolites of progesterone, synthetic progestins, 
selective progesterone receptor modulators) (Rafique & 
Decherney 2017). Different patients may demonstrate 
distinct clinical symptoms, severity of disease or location 
of lesions that might affect the efficacy of the treatment. 
The latter should, therefore, be tailored for each patient 
using the recently established endometriotic organoids 
(Fig. 3). Thus, they could be a predictive tool for assessing 
the appropriate hormonal and pharmacological regimen 
to be administered to patients.
Regenerative therapy
Endometrial regeneration after menstrual breakdown is 
unusual as it occurs without the fibrosis normally seen 
following ulceration of a mucosal surface. Scarring does 
develop if the basal layer is removed following uterine 
infection or surgery (dilation and curettage for pregnancy 
termination, cesarean section, myomectomy). The 
fibrous scarring can lead to intrauterine adhesions that 
are unresponsive to hormones and often asymptomatic. 
However, they can cause hypomenorrhoea/
amenorrhoea, recurrent miscarriages and possibly 
infertility, which are all symptoms characteristic of 
Asherman Syndrome (AS). Attempts to lyse the fibrotic 
lesions are of questionable efficacy, with a high risk 
of recurrence (Bai et  al. 2019). Cell-based therapies 
could provide an alternative for restoring endometrial 
tissue (Azizi et  al. 2018). Human umbilical cord-
derived mesenchymal stem cells on a collagen scaffold 
were transplanted into mice with artificially induced 
endometrial scarring to promote epithelial recovery and 
receptivity was enhanced (Xin et al. 2019). Autologous 
cells seeded on a biodegradable polymer scaffold could 
restore uterine structure and support pregnancies in 
rabbits (Magalhaes et al. 2020).
Organoids are an ideal source for regenerative 
medicine because they can be derived from very small 
tissue samples, expanded whilst retaining genomic 
stability and recapitulate epithelial tissue structure and 
cell types. Transplantation of autologous organoids 
derived from small endometrial biopsies to restore 
damaged epithelium would avoid allogeneic immune 
responses (Fig. 3). A similar approach to restore diseased 
or damaged organs has already been described using 
mouse colon and human liver organoids into mice (Yui 
et al. 2012, Huch et al. 2015). Critical issues that need 
to be addressed before this is adopted in the clinic are 
the safety of the graft, the timing of transplantation and 
the delivery process which needs to be targeted locally 
using biodegradable platforms. There is progress in the 
use of organoids for regenerative therapies as scalable 
GMP-grade human pancreas organoids for the treatment 
of Type 1 diabetes have been generated (Dossena et al. 
2020). This is a promising step forward for devising 
similar approaches for the treatment of infertility and 
other endometrial disorders.
Organoids could also be used as an alternative 
therapeutic approach to treat progesterone-resistant 
lesions in endometriosis. Human-induced pluripotent 
stem cells differentiated to progesterone-sensitive 
endometrial stromal cells have been used to treat 
endometriosis (Miyazaki et  al. 2018). Organoids 
could also be genetically manipulated to reinforce 
the expression of PGR and promote their response to 
progesterone and then be transferred back to the patient 
(Fig. 3). Reactivation of the PGR could also reinitiate 
the feedback loop that prevents continuous oestrogen-
mediated proliferation. Although such therapeutic 
approaches require extensive optimization, they may 
increase the chances of fertility success in patients with 
endometriosis.
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Current limitations of endometrial organoid systems 
and future perspectives
Like any other model system, endometrial organoids have 
limitations. First, they can only be used to study epithelial 
cells and the absence of stromal and immune cells is a 
limitation for studying the interactions of all endometrial 
cell types. Efforts to generate a multicellular system or 
‘artificial endometrium’ that integrates epithelial, stromal 
and immune cells using bioengineering approaches are 
needed. Such bioengineered tissues are potentially useful 
therapeutic approaches for cell replacement therapy in 
endometriosis and AS. A bioengineered endometrium 
will also provide an important tool to investigate the 
maternal–fetal interactions of early pregnancy using 
trophoblast organoids. Secondly, the apical surface of the 
endometrial organoids faces the lumen and therefore the 
development of more physiologically relevant models 
that expose the luminal surface will allow the study of 
implantation (Abbas et  al. 2020). Thirdly, endometrial 
organoids are derived from patient samples leading 
to inevitable cellular heterogeneity and variability in 
behaviour and growth, similar to other organoid models 
(Lancaster & Huch 2019). Defining the normal levels of 
variability and increasing reproducibility are essential 
if organoids are to be used for personalized medicine 
and regenerative therapy (Lancaster & Huch 2019). The 
replacement of Matrigel, an animal-derived extracellular 
matrix, with fully synthetic matrices with amenable 
biochemical and biophysical properties that mimic 
the in vivo tissue architecture more closely will be an 
important step towards this goal (Hernandez-Gordillo 
et  al. 2020). Further optimization of the composition 
of the media is also essential for organoid expansion 
or differentiation, and the use of microfluidics devices 
will lead to controllable and gradual administration of 
hormones and growth factors. The human element is also 
important and automation of organoid cultures could 
replace some of the variability introduced by different 
personnel handling the cultures with the added benefit 
of increasing scalability. Sensor systems could also be 
implemented for live assessment of the concentrations 
of the media components, hormones or other secreted 
products. Lastly, methods for derivation, culture and 
freezing of the organoids need to be fully compliant 
with good manufacturing practice. In summary, the 
endometrial organoid system in combination with 
emerging bioengineering technologies, gene editing 
and single-cell sequencing will transform the way we 
address and treat infertility of uterine origin to impact 
the lives of women.
Conclusions
Infertility is a complex, multifactorial disorder and ~30% 
of cases still remain unexplained. The endometrium 
is the site of implantation and source of nutrition for 
the developing conceptus and its altered function 
is a major cause of infertility. However, because of 
the lack of physiologically relevant in vitro models of 
the human endometrium and the dynamic nature of 
this tissue, our understanding of normal endometrial 
function throughout the menstrual cycle remains 
limited. Although different conditions – physical 
anomalies (Asherman’s syndrome, thin endometrium), 
uterine disorders (endometriosis, adenomyosis, PCOS), 
altered immunological niche (microbiome imbalances, 
infections) and lifestyle factors (age, obesity) – affect 
fertility, understanding how these conditions affect 
endometrial epithelial behaviour is still limited. 
Generating organoids from healthy and pathological 
endometrium opens up opportunities to address these 
essential questions as well as promote personalized 
medicine approaches with tailored hormonal therapies 
and regenerative therapies for the treatment of infertility.
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